Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 195793, 8 pages
http://dx.doi.org/10.1155/2014/195793
Research Article

Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain

1Laboratorio de Genética Molecular, Servicio de Genética, Hospital Universitario Cruces, BioCruces Health Research Institute, GCV-CIBER de Enfermedades Raras (CIBERER-ISCIII), Barakaldo, 48903 Bizkaia, Spain
2Unidad de Genética Molecular, Centro de Bioquímica y Genética Clínica, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, 30120 Murcia, Spain
3Unidad de Genética, Hospital Universitario La Fe, 46009 Valencia, Spain
4Laboratorio de Genética, UDIAT-Centre Diagnòstic, Corporació Sanitària Parc Taulí, Institut Universitari UAB, Sabadell, 08208 Barcelona, Spain
5Unidad de Gestión Clínica de Salud Mental, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain
6Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid, CSIC, 47003 Valladolid, Spain
7Consulta de Genética Clínica, Servicio de Pediatría, Hospital Clínico Universitario Lozano Blesa, Facultad de Medicina, Universidad de Zaragoza, GCV-CIBER de Enfermedades Raras (CIBERER-ISCIII), 50009 Zaragoza, Spain
8Servicio de Genética, Hospital Ramón y Cajal, 28034 Madrid, Spain
9Servicio de Biología Molecular, Hospital Virgen Macarena y Universidad de Sevilla, 41009 Sevilla, Spain
10Servicio de Genética, Hospital Universitari Son Espases, GCV-CIBER de Enfermedades Raras (CIBERER-ISCIII), Palma de Mallorca, 07010 Illes Balears, Spain
11Unidad de Genética Médica, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain
12Servicio de Genetica, IIS-Hospital Universitario Fundación Jiménez Díaz (IIS-FJD, UAM), CIBER de Enfermedades Raras (CIBERER-ISCIII), 28040 Madrid, Spain
13Servicio de Genética, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain
14Servicio de Bioquímica y Genética Molecular, Hospital Clinic, IDIBAPS, CIBER de Enfermedades Raras (CIBERER-ISCIII), 08036 Barcelona, Spain

Received 23 February 2014; Accepted 27 April 2014; Published 28 May 2014

Academic Editor: Emin Karaca

Copyright © 2014 María-Isabel Tejada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chonchaiya, A. Schneider, and R. J. Hagerman, “Fragile X: a family of disorders,” Advances in Pediatrics, vol. 56, no. 1, pp. 165–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Crawford, J. M. Acuña, and S. L. Sherman, “FMR1 and the fragile X syndrome: human genome epidemiology review,” Genetics in Medicine, vol. 3, no. 5, pp. 359–371, 2001. View at Google Scholar · View at Scopus
  3. I. Oberle, F. Rousseau, D. Heitz et al., “Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome,” Science, vol. 252, no. 5010, pp. 1097–1102, 1991. View at Google Scholar · View at Scopus
  4. A. Maddalena, C. S. Richards, M. J. McGinniss et al., “Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the American College of Medical Genetics,” Genetics in Medicine, vol. 3, no. 3, pp. 200–205, 2001. View at Google Scholar · View at Scopus
  5. F. Rousseau, D. Heitz, J. Tarleton et al., “A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases,” American Journal of Human Genetics, vol. 55, no. 2, pp. 225–237, 1994. View at Google Scholar · View at Scopus
  6. P. J. Hagerman, “The fragile X prevalence paradox,” Journal of Medical Genetics, vol. 45, no. 11, p. 768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Nolin, W. T. Brown, A. Glicksman et al., “Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles,” American Journal of Human Genetics, vol. 72, no. 2, pp. 454–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Strom, B. Crossley, J. B. Redman et al., “Molecular testing for fragile X syndrome: lessons learned from 119,232 tests performed in a clinical laboratory,” Genetics in Medicine, vol. 9, no. 1, pp. 46–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Vianna-Morgante, S. S. Costa, A. S. Pares, and I. T. Verreschi, “FRAXA premutation associated with premature ovarian failure,” American Journal of Medical Genetics, vol. 64, no. 2, pp. 373–375, 1996. View at Google Scholar
  10. M. D. Wittenberger, R. J. Hagerman, S. L. Sherman et al., “The FMR1 premutation and reproduction,” Fertility and Sterility, vol. 87, no. 3, pp. 456–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Tassone, R. J. Hagerman, A. K. Taylor, L. W. Gane, T. E. Godfrey, and P. J. Hagerman, “Elevated levels of FMR1 mRNA carrier males: a new mechanism of involvement in the fragile-X syndrome,” American Journal of Human Genetics, vol. 66, no. 1, pp. 6–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. E. García-Alegría, B. Ibáñez, M. Mínguez et al., “Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models,” RNA, vol. 13, no. 5, pp. 756–762, 2007. View at Google Scholar
  13. S. Jacquemont, R. J. Hagerman, M. Leehey et al., “Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates,” American Journal of Human Genetics, vol. 72, no. 4, pp. 869–878, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Fernandez-Carvajal, P. Walichiewicz, X. Xiaosen, R. Pan, P. J. Hagerman, and F. Tassone, “Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population,” Journal of Molecular Diagnostics, vol. 11, no. 4, pp. 324–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Rifé, C. Badenas, J. Mallolas et al., “Incidence of fragile X in 5,000 consecutive newborn males,” Genetic Testing, vol. 7, no. 4, pp. 339–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Millan, F. Martinez, A. Cadroy et al., “Screening for FMR1 mutations among the mentally retarded: prevalence of the fragile X syndrome in Spain,” Clinical Genetics, vol. 56, no. 1, pp. 98–99, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Biancalana, C. Beldjord, A. Taillandier et al., “Five years of molecular diagnosis of fragile X syndrome (1997–2001): a collaborative study reporting 95% of the activity in France,” American Journal of Medical Genetics, vol. 129, no. 3, pp. 218–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Berkenstadt, L. Ries-Levavi, H. Cuckle, L. Peleg, and G. Barkai, “Preconceptional and prenatal screening for fragile X syndrome: experience with 40 000 tests,” Prenatal Diagnosis, vol. 27, no. 11, pp. 991–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. L. Nolin, A. Glicksman, X. Ding et al., “Fragile X analysis of 1112 prenatal samples from 1991 to 2010,” Prenatal Diagnosis, vol. 31, no. 10, pp. 925–931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Tejada, E. Mornet, V. Biancalana et al., “Direct DNA analysis of fragile X syndrome in Spanish pedigrees,” American Journal of Medical Genetics, vol. 43, no. 1-2, pp. 282–290, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Rifé, C. Badenas, L. Quintó et al., “Analysis of CGG variation through 642 meioses in Fragile X families,” Molecular Human Reproduction, vol. 10, no. 10, pp. 773–776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-H. Fu, D. P. A. Kuhl, A. Pizzuti et al., “Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the sherman paradox,” Cell, vol. 67, no. 6, pp. 1047–1058, 1991. View at Google Scholar · View at Scopus
  23. M. Durán Domínguez, M. Molina Carrilllo, J. Fernández Toral et al., “Diagnóstico molecular por reacción en cadena de la polimerasa del Síndrome X frágil: aplicación de un protocolo diagnóstico en 50 familias del Norte de España,” Anales Españoles Pediatría, vol. 54, no. 4, pp. 331–339, 2001. View at Google Scholar
  24. F. Rousseau, D. Heitz, V. Biancalana et al., “Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation,” The New England Journal of Medicine, vol. 325, no. 24, pp. 1673–1681, 1991. View at Google Scholar · View at Scopus
  25. M. I. Tejada, E. Mornet, E. Tizzano, M. Molina, M. Baiget, and A. Boue, “Identification by molecular diagnosis of mosaic Turner's syndrome in an obligate carrier female for fragile X syndrome,” Journal of Medical Genetics, vol. 31, no. 1, pp. 76–78, 1994. View at Google Scholar · View at Scopus
  26. A. McConkie-Rosell, B. Finucane, A. Cronister, L. Abrams, R. L. Bennett, and B. J. Pettersen, “Genetic counseling for fragile X syndrome: updated recommendations of the National Society of Genetic Counselors,” Journal of Genetic Counseling, vol. 14, no. 4, pp. 249–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. B. Bailey Jr., M. Raspa, E. Bishop, and D. Holiday, “No change in the age of diagnosis for fragile X syndrome: findings from a national parent survey,” Pediatrics, vol. 124, no. 2, pp. 527–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Pembrey, A. J. Barnicoat, B. Carmichael, M. Bobrow, and G. Turner, “An assessment of screening strategies for fragile X syndrome in the UK,” Health Technology Assessment, vol. 5, no. 7, pp. 1–85, 2001. View at Google Scholar · View at Scopus
  29. S. A. Youings, A. Murray, N. Dennis et al., “FRAXA and FRAXE: the results of a five year survey,” Journal of Medical Genetics, vol. 37, no. 6, pp. 415–421, 2000. View at Google Scholar · View at Scopus
  30. I. Fernandez-Carvajal, B. L. Posadas, R. Pan, C. Raske, P. J. Hagerman, and F. Tassone, “Expansion of an FMR1 grey-zone allele to a full mutation in two generations,” Journal of Molecular Diagnostics, vol. 11, no. 4, pp. 306–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Zuñiga, J. Juan, M. Mila, and A. Guerrero, “Expansion of an intermediate allele of the FMR1 gene in only two generations,” Clinical Genetics, vol. 68, no. 5, pp. 471–473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. V. C. Wheeler, F. Persichetti, S. M. McNeil et al., “Factors associated with HD CAG repeat instability in Huntington disease,” Journal of Medical Genetics, vol. 44, no. 11, pp. 695–701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. D. S. Pavićević, J. Miladinović, M. Brkušanin et al., “Molecular genetics and genetic testing in myotonic dystrophy type 1,” BioMed Research International, vol. 2013, Article ID 391821, 13 pages, 2013. View at Publisher · View at Google Scholar